您还有0次抽奖机会
锤子
The use of monoclonal antibodies (mAb) has been accepted as an effective cure for the treatment of cancer and autoimmune diseases. Rising time and cost pressures in combination with the demand for higher throughput make the development of therapeutic antibodies challenging.
打开失败或需在电脑查看,请在电脑上的资料中心栏目,点击"我的下载"。建议使用手机自带浏览器。